Ambroxol and bromhexine are expectorants in syrup or tablet form which help make the mucus thinner and therefore easier to be cleared away in patients who . Ambroxol and bromhexine are mainly used by mouth (orally) as expectorants to help make the mucus thinner and therefore easier to be. Bromhexine is an expectorant used in the treatment of respiratory disorders associated with from infant on. Bromhexine is well established and tolerated. Sometimes it is replaced by its metabolite ambroxol, as in Mucosolvan or Mucoangin.
|Published (Last):||17 July 2017|
|PDF File Size:||7.82 Mb|
|ePub File Size:||13.56 Mb|
|Price:||Free* [*Free Regsitration Required]|
Formulations for injection are also used in premature and newborn babies to treat respiratory distress syndrome RDSa condition in which the baby’s lungs are too immature for the baby to breathe properly. In addition, the AFMPS was concerned about the use of ambroxol as expectorant bromhwxine children below 6 years of age and considered that the benefits of these medicines did not outweigh the risks in this population. This article needs additional citations for verification. Bromhexie it is replaced by its metabolite ambroxolas in Mucosolvan or Mucoangin.
From Wikipedia, the free encyclopedia. Some formulations are used to treat breathing disorders in premature and newborn babies. Bromhexine is a synthetic derivative of the herbal active ingredient vasicine. Please help improve this article by adding citations to reliable sources. In addition, bromhexine has antioxidant properties. Ambroxol and bromhexine are mainly used by mouth as expectorants to help make the mucus thinner and therefore easier to be cleared away in patients with short- or long-term diseases of the lungs or airways.
July Learn how and when to remove this template message. The European Medicines Agency has started a review of medicines containing ambroxol and bromhexine, which are widely used as expectorants medicines that help clear the airwaysas well as to relieve sore throat.
In other projects Wikimedia Commons. It is secretolytic, increasing the production of serous mucus in the respiratory tract, which makes the phlegm thinner and less viscous.
Concise Dictionary of Pharmacological Agents. It is indicated as “secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport”.
Start of review of ambroxol and bromhexine | European Medicines Agency
The posology varies with the age and weight, but there are products for all age groups from infant on. Retrieved from ” https: Lozenge formulations are also available to relieve sore throat. Leave this field blank. Medicines containing ambroxol have also been linked to severe skin adverse reactions.
Views Read Edit View history.
Some of these formulations are also used to increase lung maturation before birth. Unsourced material may be challenged and removed. Veterinary regulatory Overview Research and development Marketing authorisation Post-authorisation.
The European Medicines Agency will now review the available data on the benefits and risks of medicines containing ambroxol and bromhexine, and issue an opinion on the marketing authorisations of these medicines vromhexine the European Union EU.
Bromhexine – Wikipedia
Bromhexine is an expectorant used in the treatment of respiratory disorders associated with viscid or excessive mucus. Skip to main content. Since bromhexine gets mainly converted into ambroxol bromgexine the body, and there are some reports linking the use of bromhexine with allergic reactions, the AFMPS considered that the review should also cover medicines containing bromhexine. Human regulatory Overview Research and development Marketing authorisation Post-authorisation Herbal products.
Antioxidants Antidotes Expectorants Anilines Organobromides. The review is being carried out by the Pharmacovigilance Risk Assessment Committee PRACthe Committee responsible for the evaluation of safety issues for human medicines, which will make a set of recommendations.
This page was last edited on 18 Septemberat The CMDha body representing the EU Member States, is responsible for ensuring harmonised safety standards for medicines authorised via national procedures across the EU.
There was a problem providing the content you requested
Start of review of ambroxol and bromhexine. This follows concerns over an increased number of reports of allergic reactions, including anaphylactic severe allergic reactions with ambroxol. How useful was this page? Articles bromhezine additional references from July All articles needing additional references Template: Cough and cold preparations R More about the medicine Ambroxol and bromhexine are mainly used by mouth as expectorants to help bro,hexine the mucus thinner and therefore easier to be cleared away in patients with short- or long-term diseases of the lungs or airways.
Bromhexine is well established and tolerated.